Drug Clinical Trials List
Drug Clinical Trials List
| Study Title | Study Sponsor | Status | Study Drug | Trial Phase | Study Protocol Number | Site |
|---|---|---|---|---|---|---|
| "Open-label, multicenter, single arm, phase II study assessing treatment patient preference for new deferasirox formulation (film-coated tablet) compared to the reference deferasirox dispersible tablet formulation " | Novartis | Ongoing | deferasirox | 2 | CICL670FIC05 | KAUH-J |
| OPEN LABEL, RANDOMIZED, SINGLE SITE CLINICAL TRIAL TO COMPARE THE SAFETY & EFFICACY OF HERBAL MELANIN EXTRACTED FROM NIGELLA SATIVA SEEDS VS STANDARD OF CARE TREATMENT IN TREATING GASTRITIS PATIENTS | KAIMRC | Rejected | Melanole NIGELLA SATIVA | 2 | RC15/152/R | NGHA-R |
| Open Label, Multinational, Multicenter, Real World Treatment Study of Single Agent AZD9291 for Patients with Advanced/Metastatic Epidermal Growth Factor Receptor (EGFR)T790M Mutation-Positive Non-Small Cell Lung Cancer (NSCLC) Who Have Received Prior Therapy with an EGFR Tyrosine Kinase Inhibitor(EGFR-TKI) | AstraZeneca | Completed | Osimertinib (AZD9291) | 3 | D5160C00022 | KFSH |
| Multicentre, Randomised, Controlled, Open-label Study Comparing the Efficacy and Safety of Slow Repeated IV Infusions of 2 Doses of Doxorubicin Transdrug™ (DT) (20mg/m2 and 30mg/m2) to Those of Best Standard of Care (BSC) in Patients With Advanced Hepatocellular Carcinoma (HCC) After Failure or Intolerance to Sorafenib. ReLive Study. | Onxeo | Completed | Doxorubicin | 3 | BA2011/03/04 | KAUH-J |
| Multi-Center Open Label Study to Evaluate the Safety, Tolerability and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis on Background Non-biologic DMARDs Who Have An Inadequate Response to Current Non-Biologic DMARD or Anti-TNF Therapy | Roche | Completed | Tocilzumab | 3b | MA21573 | KFSH & RC-J |
| Multicenter Inetrnational neoadjuvant randomized double-blind trial comparing fulvestrant to a combination of fulvestrant and palcociclib in patients with operable luminal breast cancer responding to fulvestrant | ICR Group - International Cancer Research group | Ongoing | palbociclib fulvestrant | 3 | ICRG 1201 | KKUH |
| "Long-term Safety and Efficacy Study of Ferriprox® for the Treatment of Transfusional Iron Overload in Patients with Sickle Cell Disease or Other Anemias" | ApoPharma | Ongoing | Deferiprone | 3b | LA38-EXT | ACH |
| Lessening Organ Dysfunction with VITamin C | KAIMRC | Completed | ascorbic acid injection | 3 | CT19/022/R | King Abdulaziz Medical City NG (Riyadh) |
| Ketamine for Acute Painful Crisis in Sickle Cell Disease Patients: Prospective Randomized Control trial | King Fahad Hospital of the University | Completed | Ketamine | 3 | 2016-01-042 -Version 02 | KFUH |
| Intra Peritoneal Instillation of Ropivacaine with or without Dexmedetomidine for Postoperative Analgesia After Laparoscopic Sleeve Gastrectomy. A randomized controlled | King Abdullah Medical City, Makkah | Completed | Dexmedetomidine | 2 | version 4 | KAMC |